IDEXX Laboratories Revenue vs. Gross Profit

IDXX Stock  USD 506.38  1.28  0.25%   
Based on IDEXX Laboratories' profitability indicators, IDEXX Laboratories is performing exceptionally good at this time. It has a great probability to showcase excellent profitability results in October. Profitability indicators assess IDEXX Laboratories' ability to earn profits and add value for shareholders.
 
Total Revenue  
First Reported
1991-03-31
Previous Quarter
964.1 M
Current Value
B
Quarterly Volatility
265.5 M
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
At this time, IDEXX Laboratories' Price To Sales Ratio is fairly stable compared to the past year. Days Sales Outstanding is likely to rise to 58.10 in 2024, whereas Sales General And Administrative To Revenue is likely to drop 0.09 in 2024. At this time, IDEXX Laboratories' Operating Income is fairly stable compared to the past year. Income Before Tax is likely to rise to about 1.1 B in 2024, despite the fact that Accumulated Other Comprehensive Income is likely to grow to (67.6 M).
Current ValueLast YearChange From Last Year 10 Year Trend
Gross Profit Margin0.610.5982
Fairly Up
Slightly volatile
Net Profit Margin0.240.2308
Sufficiently Up
Slightly volatile
Operating Profit Margin0.310.2997
Sufficiently Up
Slightly volatile
Pretax Profit Margin0.30.2899
Sufficiently Up
Slightly volatile
Return On Assets0.270.2592
Sufficiently Up
Slightly volatile
For IDEXX Laboratories profitability analysis, we use financial ratios and fundamental drivers that measure the ability of IDEXX Laboratories to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well IDEXX Laboratories utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between IDEXX Laboratories's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of IDEXX Laboratories over time as well as its relative position and ranking within its peers.
  

IDEXX Laboratories' Revenue Breakdown by Earning Segment

Check out Risk vs Return Analysis.
For more information on how to buy IDEXX Stock please use our How to Invest in IDEXX Laboratories guide.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of IDEXX Laboratories. If investors know IDEXX will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about IDEXX Laboratories listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.09)
Earnings Share
10.08
Revenue Per Share
45.612
Quarterly Revenue Growth
0.064
Return On Assets
0.2277
The market value of IDEXX Laboratories is measured differently than its book value, which is the value of IDEXX that is recorded on the company's balance sheet. Investors also form their own opinion of IDEXX Laboratories' value that differs from its market value or its book value, called intrinsic value, which is IDEXX Laboratories' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because IDEXX Laboratories' market value can be influenced by many factors that don't directly affect IDEXX Laboratories' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between IDEXX Laboratories' value and its price as these two are different measures arrived at by different means. Investors typically determine if IDEXX Laboratories is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, IDEXX Laboratories' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

IDEXX Laboratories Gross Profit vs. Revenue Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining IDEXX Laboratories's current stock value. Our valuation model uses many indicators to compare IDEXX Laboratories value to that of its competitors to determine the firm's financial worth.
IDEXX Laboratories is rated below average in revenue category among its peers. It also is rated below average in gross profit category among its peers fabricating about  0.55  of Gross Profit per Revenue. The ratio of Revenue to Gross Profit for IDEXX Laboratories is roughly  1.83 . At this time, IDEXX Laboratories' Total Revenue is fairly stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the IDEXX Laboratories' earnings, one of the primary drivers of an investment's value.

IDEXX Laboratories' Earnings Breakdown by Geography

IDEXX Revenue vs. Competition

IDEXX Laboratories is rated below average in revenue category among its peers. Market size based on revenue of Health Care industry is currently estimated at about 118.74 Billion. IDEXX Laboratories holds roughly 3.66 Billion in revenue claiming about 3% of equities under Health Care industry.

IDEXX Gross Profit vs. Revenue

Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.

IDEXX Laboratories

Revenue

 = 

Money Received

-

Discounts and Returns

 = 
3.66 B
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments.

IDEXX Laboratories

Gross Profit

 = 

Revenue

-

Cost of Revenue

 = 
B
Gross Profit varies significantly from one sector to another and tells an investor how much money a business would have made if it didn't have to pay any overhead expenses such as salary, taxes, or rent.

IDEXX Gross Profit Comparison

IDEXX Laboratories is currently under evaluation in gross profit category among its peers.

IDEXX Laboratories Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in IDEXX Laboratories, profitability is also one of the essential criteria for including it into their portfolios because, without profit, IDEXX Laboratories will eventually generate negative long term returns. The profitability progress is the general direction of IDEXX Laboratories' change in net profit over the period of time. It can combine multiple indicators of IDEXX Laboratories, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last ReportedProjected for Next Year
Accumulated Other Comprehensive Income-71.2 M-67.6 M
Operating Income1.1 B1.2 B
Income Before Tax1.1 B1.1 B
Total Other Income Expense Net-36 M-34.2 M
Net Income845 M887.3 M
Income Tax Expense216.1 M226.9 M
Net Income Applicable To Common Shares781 M820 M
Net Income From Continuing Ops822.7 M417 M
Non Operating Income Net Other958.5 K1.5 M
Interest Income2.2 M3.7 M
Net Interest Income-43.6 M-45.8 M
Change To Netincome29.4 M28.4 M
Net Income Per Share 10.17  10.68 
Income Quality 1.07  0.79 
Net Income Per E B T 0.80  1.18 

IDEXX Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on IDEXX Laboratories. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of IDEXX Laboratories position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the IDEXX Laboratories' important profitability drivers and their relationship over time.

Use IDEXX Laboratories in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if IDEXX Laboratories position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in IDEXX Laboratories will appreciate offsetting losses from the drop in the long position's value.

IDEXX Laboratories Pair Trading

IDEXX Laboratories Pair Trading Analysis

The ability to find closely correlated positions to IDEXX Laboratories could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace IDEXX Laboratories when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back IDEXX Laboratories - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling IDEXX Laboratories to buy it.
The correlation of IDEXX Laboratories is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as IDEXX Laboratories moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if IDEXX Laboratories moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for IDEXX Laboratories can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your IDEXX Laboratories position

In addition to having IDEXX Laboratories in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Hedge Favorites Thematic Idea Now

Hedge Favorites
Hedge Favorites Theme
Hedge Funds pool capital from accredited individuals or institutional investors and invest in a variety of assets, often with complex portfolio-construction and risk-management techniques. The Hedge Favorites theme has 37 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Hedge Favorites Theme or any other thematic opportunities.
View All  Next Launch

Additional Tools for IDEXX Stock Analysis

When running IDEXX Laboratories' price analysis, check to measure IDEXX Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy IDEXX Laboratories is operating at the current time. Most of IDEXX Laboratories' value examination focuses on studying past and present price action to predict the probability of IDEXX Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move IDEXX Laboratories' price. Additionally, you may evaluate how the addition of IDEXX Laboratories to your portfolios can decrease your overall portfolio volatility.